Thursday, January 26, 2012

The whistleblower speaks

Johnson and Johnson has agreed to pay $158 million to settle a Texas lawsuit over its controversial Texas Medication Algorithm Project (TMAP), which was allegedly designed to increase sales of the antipsychotic Risperdal.  The whistleblower in the case was Allen Jones, a Pennsylvania state investigator who uncovered the program.  For years he has been unable to speak publicly about TMAP.  Yesterday, he was interviewed by Ed Silverman at Pharmalot.

No comments:

Post a Comment